D
Charles River Laboratories International, Inc. CRL
$163.71 -$0.40-0.24% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/28/2025 03/29/2025 12/28/2024 09/28/2024 06/29/2024
Net Income 105.45% 111.87% -407.93% -30.14% 48.10%
Total Depreciation and Amortization 82.65% -8.46% 5.11% 2.46% 0.85%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -123.13% -81.43% 1,341.46% 17.68% -24.59%
Change in Net Operating Assets 767.68% 103.04% -159.30% 730.88% 76.44%
Cash from Operations 19.17% 7.74% -36.71% 30.10% 49.00%
Capital Expenditure 40.50% 21.55% -95.28% 1.94% 50.11%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 100.00% --
Divestitures -100.00% -- -- -- --
Other Investing Activities 43.24% -636.89% -102.81% 202.93% -154.23%
Cash from Investing 17.90% 40.24% -256.89% 65.53% 27.89%
Total Debt Issued 31.39% 297.28% -55.52% -46.50% 46.34%
Total Debt Repaid -394.20% 15.49% 46.37% 52.56% -137.57%
Issuance of Common Stock -- -- -1.41% -5.69% -96.16%
Repurchase of Common Stock 97.92% -284,683.87% 99.88% -1,030.65% 4.67%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -47.75% -321.40% 66.27% 42.02% -951.90%
Cash from Financing -115.45% -38.81% 63.44% 27.40% -1,658.15%
Foreign Exchange rate Adjustments 140.63% 139.15% -274.57% 330.52% 60.15%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -279.63% 530.94% -119.81% 119.45% -391.43%